Ragwitek 12 Amb a 1-U Sublingual Tablet
- RxCUI
- 1495470
- RxNorm name
- Ragwitek 12 Amb a 1-U Sublingual Tablet
- Display name
- Ragwitek 12 Amb a 1-U Sublingual Tablet
- Full name
- Ragwitek 12 Amb a 1-U Sublingual Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125478 | Ragwitek | Short Ragweed Pollen Allergen Extract | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 70216cba-11b5-40fd-8656-9f27b24f7b60 | Ragwitek 12 Amb a 1-U Sublingual Tablet [PSN] · short ragweed pollen extract 12 Amb a 1-U Sublingual Tablet [Ragwitek] [SBD] · Ragwitek 12 Amb a 1-U Sublingual Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use RAGWITEK safely and effectively. See full prescribing information for RAGWITEK . RAGWITEK ® (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual U se Initial U.S. Approval: 2014 | 20220919 |